A Phase IB Dose-Escalation Study of TRC105 in combination with Pazopanib in Patients with Advanced Soft Tissue Sarcoma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Tracon Pharmaceuticals, Inc.
Start Date
November 1, 2013
End Date
August 27, 2020
Administered By
Duke Cancer Institute
Awarded By
Tracon Pharmaceuticals, Inc.
Start Date
November 1, 2013
End Date
August 27, 2020